Showing results (431-440 of 500) with videos related to

Sort By:
Pageof 50
AIDS (London, England)|May 16, 2018
A defucosylated bispecific multivalent molecule exhibits broad HIV-1-neutralizing activity and enhanced antibody-dependent cellular cytotoxicity against reactivated HIV-1 latently infected cellsDesheng Kong, Yan Wang, Ping Ji, et al.
The Journal of Biological Chemistry|May 2, 2006
Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formationStephen A Gallo, Wei Wang, Satinder S Rawat, et al.
Vaccine|October 11, 2020
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancementWen-Hsiang Chen, Xinrong Tao, Anurodh Shankar Agrawal, et al.
Virology|June 24, 2006
Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccinesLanying Du, Yuxian He, Yijia Wang, et al.
Cellular & Molecular Immunology|December 20, 2011
Identification of HBsAg-specific antibodies from a mammalian cell displayed full-length human antibody library of healthy immunized donorChang-Zheng Li, Zhong-Kun Liang, Zhen-Rui Chen, et al.
Signal Transduction and Targeted Therapy|December 18, 2022
Analogous comparison unravels heightened antiviral defense and boosted viral infection upon immunosuppression in bat organoidsXiaojuan Liu, Cun Li, Zhixin Wan, et al.
Immunity|September 23, 2021
Inhibition of viral suppressor of RNAi proteins by designer peptides protects from enteroviral infection in vivoYuan Fang, Zezhong Liu, Yang Qiu, et al.
Journal of Medicinal Chemistry|June 18, 2024
Discovery of a Double-Stapled Short Peptide as a Long-Acting HIV-1 Inactivator with Potential for Oral BioavailabilityChao Wang, Wenpeng Zhang, Ling Xu, et al.
Current Research in Microbial Sciences|June 4, 2026
Antiviral potential of black tea and blueberry extracts against monkeypox virus by targeting orthopoxvirus surface proteinsYi'ou Sha, Yixin Li, Yanchen Liu, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2012
L-selectin and P-selectin are novel biomarkers of cervicovaginal inflammation for preclinical mucosal safety assessment of anti-HIV-1 microbicideMaohua Zhong, Benxia He, Jingyi Yang, et al.
Pageof 50